| Literature DB >> 27881905 |
Frank Rijmen1, Edward H Ip2, Stephen Rapp2, Edward G Shaw2.
Abstract
Primary and metastatic brain tumour patients are treated with surgery, radiation therapy and chemotherapy. Such treatments often result in short- and long-term symptoms that impact cognitive, emotional and physical function. Therefore, understanding the transition of symptom burden over time is important for guiding treatment and follow-up of brain tumour patients with symptom-specific interventions. We describe the use of a hidden Markov model with person-specific random effects for the temporal pattern of symptom burden. Clinically relevant covariates are also incorporated in the analysis through the use of generalized linear models.Entities:
Keywords: Brain tumours; Hidden Markov model; Latent class; Quality of life; Transition probability
Year: 2008 PMID: 27881905 PMCID: PMC5118046 DOI: 10.1111/j.1467-985x.2008.00529.x
Source DB: PubMed Journal: J R Stat Soc Ser A Stat Soc ISSN: 0964-1998 Impact factor: 2.483